In 2023, the trade exchange (includes international purchases and sales) of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) was US$36.9M.
In 2023, the states with the most international sales in Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were Ciudad de México (US$12.1M).
The states with the most international purchases in 2023 were Ciudad de México (US$9.61M), Jalisco (US$4.47M), Estado de México (US$1.43M), Nuevo León (US$819k), and Querétaro (US$361k).
In 2023, the main commercial destinations of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were United States (US$4.65M), Brazil (US$3.16M), Spain (US$1.41M), Italy (US$1.09M), and China (US$676k).
The main commercial origins of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2023 were China (US$6.33M), United States (US$5.22M), Germany (US$3.22M), Philippines (US$1.66M), and Belgium (US$117k).
In the global context, the main exporting countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2022 were China (US$632M), Germany (US$242M), and United States (US$189M). In the same year, the main importing countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were United States (US$220M), Germany (US$133M), and South Korea (US$105M).